S'identifier

Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.

Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including the liver, lungs, and biliary system. The sum of clearances by all eliminating organs is known as the total body or systemic clearance. It can be expressed as a combination of renal clearance and nonrenal clearance.

Understanding drug elimination kinetics and the concept of drug clearance is essential for designing effective dosage regimens and ensuring safe and optimal drug therapy. It allows for individualized adjustments based on a person's specific needs.

Exceeding the prescribed dosing rate can overload elimination pathways and decrease drug clearance. This leads to elevated plasma drug concentrations, which can result in toxic levels and cause adverse effects.

Tags
Drug EliminationClearancePharmacokinetic ParameterRenal ExcretionLiverBiliary SystemTotal Body ClearanceSystemic ClearanceRenal ClearanceNonrenal ClearanceDrug Elimination KineticsDosage RegimensPlasma Drug ConcentrationsToxic Levels

Du chapitre 3:

article

Now Playing

3.22 : Drug Elimination: The Concept of Clearance

Pharmacokinetics

2.3K Vues

article

3.1 : Pharmacocinétique : Vue d’ensemble

Pharmacokinetics

4.6K Vues

article

3.2 : Mécanisme d’absorption du médicament : transport membranaire passif

Pharmacokinetics

3.2K Vues

article

3.3 : Mécanisme d’absorption du médicament : transport membranaire médié par le transporteur

Pharmacokinetics

3.1K Vues

article

3.4 : Absorption des médicaments : facteurs affectant l’absorption gastro-intestinale

Pharmacokinetics

3.4K Vues

article

3.5 : Biodisponibilité : Vue d’ensemble

Pharmacokinetics

2.3K Vues

article

3.6 : Facteurs influençant la biodisponibilité : élimination au premier passage

Pharmacokinetics

5.7K Vues

article

3.7 : Bioéquivalence : Vue d’ensemble

Pharmacokinetics

843 Vues

article

3.8 : Effet de premier passage

Pharmacokinetics

4.7K Vues

article

3.9 : Évolution temporelle de l’effet du médicament

Pharmacokinetics

1.8K Vues

article

3.10 : Distribution du médicament : liaison tissulaire

Pharmacokinetics

2.3K Vues

article

3.11 : Barrières physiologiques

Pharmacokinetics

3.1K Vues

article

3.12 : Distribution du médicament : liaison aux protéines plasmatiques

Pharmacokinetics

3.9K Vues

article

3.13 : Modèles à compartiments : Modèle à compartiment unique

Pharmacokinetics

1.9K Vues

article

3.14 : Modèles à compartiments : Modèle à deux compartiments

Pharmacokinetics

4.8K Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.